Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation
Shiyu He(Peking University), Qian Jiang(Peking University), Jinxia Zhao(Peking University), Lin Huang(Sun Yat-sen University), Qian-Hang Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuanyuan Li(Chongqing University of Science and Technology), Lei Hu(Wuxi No.2 People's Hospital), Xu Hao(China Pharmaceutical University), Huan He(Bristol-Myers Squibb (United States)), Jialu Bian(Peking University), Boyu Liu(Nanchang University), Yinyu Zhao(Peking University)
Cited by 7
Related Papers
Studies on the structure-activity relationship and interaction mechanism of flavonoids and xanthine oxidase through enzyme kinetics, spectroscopy methods and molecular simulations
|Food Chemistry|2020|156
Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
|Brain|2023|130
Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-3
|Archives of Medical Research|2020|91